Advertisement

Topics

EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Avalanche Biotechnologies, Inc. -- AAVL

20:00 EDT 6 Aug 2015 | Globe Newswire

NEW YORK, Aug. 7, 2015 (GLOBE NEWSWIRE) -- The Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Avalanche Biotechnologies, Inc. (NASDAQ:AAVL) securities (1) pursuant and/or traceable to the Company's Initial Public Offering on or about July 31, 2014; and/or (2) on the open market between July 31, 2014 and June 15, 2015, both dates inclusive (the "Class Period"). The lawsuit seeks to recover damages for Avalanche Biotechnologies investors under the federal securities laws.

To join the Avalanche Biotechnologies class action, go to the firm's website at http://www.rosenlegal.com/cases-642.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action. The lawsuit is pending in U.S. District Court for the Northern District of California.

NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.

According to the lawsuit, Defendants made materially false and/or misleading statements and failed to disclose that Phase 2a of the AVA-101 study was not designed to show any statistical significance between the active and control groups in the secondary endpoints. When the true details entered the market, the lawsuit claims that investors suffered damages.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 8, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm's website at http://www.rosenlegal.com/cases-642.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of The Rosen Law Firm, toll-free, at 866-767-3653, or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

CONTACT: Laurence Rosen, Esq.
         Phillip Kim, Esq.
         Kevin Chan, Esq.
         The Rosen Law Firm, P.A.
         275 Madison Avenue, 34th Floor
         New York, NY  10016
         Tel: (212) 686-1060
         Toll Free: (866) 767-3653
         Fax: (212) 202-3827
         lrosen@rosenlegal.com
         pkim@rosenlegal.com
         kchan@rosenlegal.com
         www.rosenlegal.com
NEXT ARTICLE

More From BioPortfolio on "EQUITY ALERT: The Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Avalanche Biotechnologies, Inc. -- AAVL"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...